Risk assessment in severe pulmonary hypertension due to interstitial lung disease

A. Yogeswaran (Giessen, Germany), M. Faber (Giessen, Germany), K. Tello (Giessen, Germany), N. Sommer (Giessen, Germany), H. Ghofrani (Giessen, Germany), W. Seeger (Giessen, Germany), M. Richter (Giessen, Germany), H. Gall (Giessen, Germany)

Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Session: Pulmonary hypertension in lung diseases
Session type: E-poster session
Number: 289
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Yogeswaran (Giessen, Germany), M. Faber (Giessen, Germany), K. Tello (Giessen, Germany), N. Sommer (Giessen, Germany), H. Ghofrani (Giessen, Germany), W. Seeger (Giessen, Germany), M. Richter (Giessen, Germany), H. Gall (Giessen, Germany). Risk assessment in severe pulmonary hypertension due to interstitial lung disease. 289

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: